Category: united states

Stem cell researcher who sued Harvard, Brigham & Women’s is leaving his post

anversa
Piero Anversa
A stem cell researcher who sued his employers, Harvard and Brigham & Women’s Hospital, is headed to Switzerland.

Piero Anversa‘s departure follows the dismissal of his suit last summer. Anversa filed the suit with colleague Annarosa Leri, claiming that an investigation into their work damaged their reputations:

they lost a multimillion-dollar offer to purchase their company, Autologous/Progenital; and both Plaintiffs have had possible employment offers at several institutions postponed.

Anversa’s lawyer, Tracey Miner, confirmed that he was moving:

Continue reading Stem cell researcher who sued Harvard, Brigham & Women’s is leaving his post

Yale doc loses 2 HuffPo blog posts after secretly promoting his novel

Screen Shot 2015-11-20 at 8.54.44 AM
David Katz

The Huffington Post has retracted two blog posts by prominent Yale nutritionist David Katz after learning he had posted incredibly favorable reviews of a new novel — and not revealed that he had written the novel himself, under a pseudonym.

There’s no doubt Katz is a prolific writer — in addition to a couple hundred scientific articles and textbook chapters, Katz regularly blogs for the Huffington Post. He’s also the author of a novel, reVision, under the pen name Samhu Iyyam. Last year, Katz wrote a pair of incredibly favorable reviews of reVision on The Huffington Post that implied he had discovered the novel as a reader. The Huffington Post has taken them down, as blogger Peter Heimlich — yes, related to the maneuver — reported earlier this week. According to Heimlich, a 5-star Amazon review of “Iyyam’s” book, written by Katz, has also been removed.

In the reviews, there’s no hint that Katz is the author. In the first column, “Do We Need to Kill Our Heroes?,” published in January, Katz notes he was “delighted to find just such reflections [on that question] in my new favorite book, reVision.” Here’s the retraction note, of sorts, that appears on Huff Po in the column’s place:

Continue reading Yale doc loses 2 HuffPo blog posts after secretly promoting his novel

Mol bio paper pulled by PLOS following investigation into figures

Screen Shot 2015-11-17 at 11.58.47 AMPLOS Biology has retracted a paper about the molecular details of β-catenin expression following an investigation by the first author’s institution in Italy.

The investigation, by the Istituto Nazionale per la Ricerca sul Cancro, found that there were multiple “figure anomalies.” According to the note:

An explanation of inadvertent error was given for some of the issues identified, while for two issues, a satisfactory explanation could not be provided.

First author Roberto Gherzi says none of his co-authors helped prepare the figures. The authors maintain that the conclusions are unaffected, but that assurance wasn’t enough for the journal. Here’s more from the lengthy retraction note, which provides some backstory on the “serious concerns” regarding the data:

Continue reading Mol bio paper pulled by PLOS following investigation into figures

MD Anderson researcher Aggarwal up to six corrections

cover (2)A highly cited cancer researcher at MD Anderson has notched three major corrections, all associated with problems in figures. One note cites “human error” as the cause.

Bharat Aggarwal is the last author on all three papers. He is now up to six corrections, two unexplained withdrawals, and two Expressions of Concern. He’s also threatened to sue us in the past, and has told us that his institution has been looking into his work.

Only one note specifies that the correction does not affect the paper’s conclusions.

First up: “Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling,” published in the International Journal of Cancer and cited 168 times, according to Thomson Scientific’s Web of Knowledge. The issues span two figures, according to the erratum note:

Continue reading MD Anderson researcher Aggarwal up to six corrections

Heart researcher gets 3rd retraction for copying images of rat hearts

1-s2.0-S0014299914X00233-cov150hWhen two papers include the same images of rat hearts, one of those papers gets retracted.

The papers share a corresponding author, Zhi-Qing Zhao of Mercer University School of Medicine in Savannah, Georgia. This marks his third retraction; we reported on two others earlier this year.

The papers examine the effect of curcumin, which has antinflammatory properties (in addition to giving the spice turmeric its yellow color). The retracted paper, “Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarctionin rat heart,” was published in the January 5, 2015 issue of the European Journal of Pharmacology, and has zero citations, according to Thomson Scientific’s Web of Knowledge. It shares multiple figures with another 2012 paper, “Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction,” published in the British Journal of Pharmacology, which has not been retracted. The BJP paper has been cited 18 times.

Here’s the retraction note for the EJP paper:

Continue reading Heart researcher gets 3rd retraction for copying images of rat hearts

Chronic fatigue syndrome-XMRV researcher scheduled to head to court today, alleging conspiracy

Judy Mikovits
Judy Mikovits

Chronic fatigue syndrome researcher Judy Mikovits was scheduled to head is heading to court today, where a California judge will would decide whether or not to dismiss her lawsuit against fourteen people and two Nevada corporations.

(Note: This story has been updated. See below.)

Among the defendants: the Whittemore Peterson Institute  in Reno, Nevada where Mikovits used to work; the institute’s cofounders, Annette and Harvey Whittemore; a colleague with whom she shares a retracted Science paper; and several members of California and Nevada law enforcement.

The complaint does not check the box next to “Money Demanded in Complaint”, but also lists $750,000 in the associated field:

Screen Shot 2015-11-16 at 11.28.23 AM

In 2006, Mikovits began working for the Whittmores at the WPI; her job was to search for a biological cause of chronic fatigue, a vexing, mysterious disease afflicting their daughter. Part of her research focused on a potential link between chronic fatigue syndrome and a virus known as XMRV. But after others — and Mikovits herself — couldn’t replicate results published in Science and the paper was retracted, she was fired from her position in 2011. Mikovits alleges that Continue reading Chronic fatigue syndrome-XMRV researcher scheduled to head to court today, alleging conspiracy

Nutritionist group pulls position statement on vegetarian diets for “inaccuracies and omissions”

Screen Shot 2015-10-16 at 11.57.38 AMWhat are the specific health benefits to skipping out on meat? We’re not totally sure, after the largest organization for nutrition professionals pulled its 2015 position statement on this issue only weeks after publishing it in the Journal of the Academy of Nutrition and Dietetics.

The “Position of the Academy of Nutrition and Dietetics: Vegetarian Diets” was removed earlier this year for “inaccuracies and omissions critical to the paper” — and the first author wasn’t told what they were. A “major revision” is forthcoming.

Here’s the removal note from the journal for the 2015 version:

Continue reading Nutritionist group pulls position statement on vegetarian diets for “inaccuracies and omissions”

Can linguistic patterns identify data cheats?

JLAPSCunning science fraudsters may not give many tells in their data, but the text of their papers may be a tipoff to bad behavior.

That’s according to a new paper in the Journal of Language and Social Psychology by a pair of linguists at Stanford University who say that the writing style of data cheats is distinct from that of honest authors. Indeed, the text of science papers known to contain fudged data tends to be more opaque, less readable and more crammed with jargon than untainted articles.

The authors, David Markowitz and Jeffrey Hancock, also found that papers with faked data appear to be larded up with references – possibly in an attempt to make the work more cumbersome for readers to wade through, or to tart up the manuscript to make it look more impressive and substantial. As Markowitz told us: Continue reading Can linguistic patterns identify data cheats?

Intellectual property issues sink cancer paper in JACS

176 spine minimum. full size. Editor: Lingling JEM: Leslie RTP: Michael ReidThe authors of a paper on a mechanism for potential cancer therapies are retracting it after realizing they published some proprietary findings “without permission and agreement from St. Jude Children’s Research Hospital.”

According to the retraction note in Journal of the American Chemical Society, the authors included an X-ray crystal structure and data that were gathered at St. Jude’s and considered the hospital’s intellectual property. On the paper, the last author, Zhengding Su, listed an affiliation at St. Jude and Hubei University of Technology in China, along with Amersino Biodevelop Inc., based in Waterloo, Canada.

Here’s the note for “Efficient Reactivation of p53 in Cancer Cells by a Dual MdmX/Mdm2 Inhibitor:”  Continue reading Intellectual property issues sink cancer paper in JACS

“Most responsible course of action is to retract:” Duplicated images fell prostate cancer paper

International Journal of CancerA study on the cellular interactions underlying prostate cancer has been retracted after a whistleblower pointed out duplicated images in one of the paper’s figures that were “erroneously presented as unique.”

The International Journal of Cancer posted the notice in June. The authors backed the paper’s conclusions but agreed, “the most responsible course of action is to retract.”

The notice reads:

Continue reading “Most responsible course of action is to retract:” Duplicated images fell prostate cancer paper